A. C. Sharada

821 total citations
27 papers, 681 citations indexed

About

A. C. Sharada is a scholar working on Molecular Biology, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. C. Sharada has authored 27 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. C. Sharada's work include Phytochemicals and Medicinal Plants (5 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Curcumin's Biomedical Applications (3 papers). A. C. Sharada is often cited by papers focused on Phytochemicals and Medicinal Plants (5 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Curcumin's Biomedical Applications (3 papers). A. C. Sharada collaborates with scholars based in India. A. C. Sharada's co-authors include F E Solomon, P. Uma Devi, Madhusudhana Kamath, N Udupa, C Madhu, Kanchugarakoppal S. Rangappa, P. Uma Devi, C. S. Ananda Kumar, B. K. Bettadaiah and N. R. Thimmegowda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Ethnopharmacology and Cancer Letters.

In The Last Decade

A. C. Sharada

27 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. C. Sharada India 13 347 203 135 90 62 27 681
Biswajit Chakraborty India 13 191 0.6× 196 1.0× 88 0.7× 81 0.9× 66 1.1× 23 577
F E Solomon India 9 354 1.0× 171 0.8× 126 0.9× 54 0.6× 50 0.8× 10 563
M Sreepriya India 12 123 0.4× 201 1.0× 90 0.7× 62 0.7× 75 1.2× 23 526
Sukhdev Singh India 7 116 0.3× 330 1.6× 92 0.7× 49 0.5× 75 1.2× 17 620
Suman Kumar Samanta India 16 145 0.4× 387 1.9× 175 1.3× 90 1.0× 45 0.7× 31 714
Kanokkarn Phromnoi Thailand 13 124 0.4× 329 1.6× 148 1.1× 46 0.5× 98 1.6× 18 767
Asif Jafri India 14 83 0.2× 243 1.2× 107 0.8× 88 1.0× 56 0.9× 33 632
Syam Mohan Malaysia 16 168 0.5× 309 1.5× 247 1.8× 63 0.7× 95 1.5× 29 859
D. Bharat Reddy India 5 121 0.3× 199 1.0× 76 0.6× 43 0.5× 76 1.2× 14 436
Pushpesh Kumar Mishra India 9 97 0.3× 223 1.1× 142 1.1× 134 1.5× 64 1.0× 11 632

Countries citing papers authored by A. C. Sharada

Since Specialization
Citations

This map shows the geographic impact of A. C. Sharada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. C. Sharada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. C. Sharada more than expected).

Fields of papers citing papers by A. C. Sharada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. C. Sharada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. C. Sharada. The network helps show where A. C. Sharada may publish in the future.

Co-authorship network of co-authors of A. C. Sharada

This figure shows the co-authorship network connecting the top 25 collaborators of A. C. Sharada. A scholar is included among the top collaborators of A. C. Sharada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. C. Sharada. A. C. Sharada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rao, Mahendra S., et al.. (2023). Comparative evaluation of bioactive phytochemicals and cytotoxic activity of unripe and ripe aril extracts of Pithecellobium dulce (Roxb.) Benth.. Annals of Phytomedicine An International Journal. 12(2). 3 indexed citations
2.
3.
Sharada, A. C., et al.. (2021). Sericin, a Versatile Protein from Silkworm - Biomedical Applications. Shanlax International Journal of Arts Science and Humanities. 8(S1-Feb). 6–11. 3 indexed citations
4.
Madhu, C, et al.. (2019). Antitumor effects of chitin specific lectin from Praecitrullus fistulosus by targeting angiogenesis and apoptosis. Biochemical and Biophysical Research Communications. 518(2). 381–387. 13 indexed citations
5.
Madhu, C & A. C. Sharada. (2019). Fibrinogenolytic activity of serine proteases(s) from Cucumis dipsaceus. Biocatalysis and Agricultural Biotechnology. 17. 685–689. 6 indexed citations
6.
Sharada, A. C., et al.. (2017). Biochemical Evaluation of Cordia dichotoma Seed Extracts. Advanced Science Letters. 23(3). 1823–1825. 3 indexed citations
7.
Madhu, C, et al.. (2017). Anticancer effect of silver nanoparticles (AgNP’s) from Decalepis hamiltonii: An in vivo approach. Materials Today Proceedings. 4(11). 11947–11958. 14 indexed citations
8.
Sharada, A. C., et al.. (2015). Comparative evaluation of 6-fluoro-3-(piperidin-4-yl) benzo[d] isoxazole derivatives and atypical antipsychotics for their anti-diabetic properties. International Journal of Bioassays. 4(6). 3964–3967. 1 indexed citations
9.
Sharada, A. C., et al.. (2014). Benzisoxazole derivatives as Atypical Antipsychotic drugs: A Review. 2 indexed citations
10.
Sharada, A. C., et al.. (2010). Antiangiogenic effects of synthetic analogs of curcumin in vivo. African Journal of Biomedical Research. 10(3). 3 indexed citations
11.
Chandrappa, S., A. C. Sharada, K. Vinaya, et al.. (2009). Synthesis and in vivo anticancer and antiangiogenic effects of novel thioxothiazolidin-4-one derivatives against transplantable mouse tumor. Medicinal Chemistry Research. 19(3). 236–249. 21 indexed citations
14.
Sharada, A. C., et al.. (2007). Expression of matrix metalloproteinase (MMP-2) and extracellular matrix metalloproteinases inducer (EMMPRIN) in benign and advanced breast cancer tissue samples. Biochemistry (Moscow) Supplement Series B Biomedical Chemistry. 1(4). 348–352. 7 indexed citations
15.
Sharada, A. C., et al.. (2007). In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor. Bioorganic & Medicinal Chemistry. 15(24). 7696–7703. 54 indexed citations
16.
Devi, P. Uma, F E Solomon, & A. C. Sharada. (1999). Plumbagin, A Plant Naphthoquinone with Antitumor and Radiomodifying Properties. Pharmaceutical Biology. 37(3). 231–236. 33 indexed citations
17.
Sharada, A. C., et al.. (1996). Antitumor and Radiosensitizing Effects of Withaferin a on Mouse Ehrlich Ascites Carcinoma in vivo. Acta Oncologica. 35(1). 95–100. 104 indexed citations
18.
Devi, P. Uma, A. C. Sharada, & F E Solomon. (1995). In vivo growth inhibitory and radiosensitizing effects of withaferin A on mouse Ehrlich ascites carcinoma. Cancer Letters. 95(1-2). 189–193. 58 indexed citations
19.
Solomon, F E, A. C. Sharada, & P. Uma Devi. (1993). Toxic effects of crude root extract of Plumbago rosea (Rakta chitraka) on mice and rats. Journal of Ethnopharmacology. 38(1). 79–84. 40 indexed citations
20.
Devi, P. Uma, A. C. Sharada, & F E Solomon. (1993). Antitumor and radiosensitizing effects of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, Sarcoma-180.. PubMed. 31(7). 607–11. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026